Abstract:Summary Background Accurately distinguishing between malignant and benign thyroid nodules through fine-needle aspiration cytopathology is crucial for appropriate therapeutic intervention. However, cytopathologic diagnosis is time consuming and hindered by the shortage of experienced cytopathologists. Reliable assistive tools could improve cytopathologic diagnosis efficiency and accuracy. We aimed to develop and test an artificial intelligence (AI)-assistive system for thyroid cytopathologic diagnosis according to the Thyroid Bethesda Reporting System. Methods 11 254 whole-slide images (WSIs) from 4037 patients were used to train deep learning models. Among the selected WSIs, cell level was manually annotated by cytopathologists according to The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) guidelines of the second edition (2017 version). A retrospective dataset of 5638 WSIs of 2914 patients from four medical centres was used for validation. 469 patients were recruited for the prospective study of the performance of AI models and their 537 thyroid nodule samples were used. Cohorts for training and validation were enrolled between Jan 1, 2016, and Aug 1, 2022, and the prospective dataset was recruited between Aug 1, 2022, and Jan 1, 2023. The performance of our AI models was estimated as the area under the receiver operating characteristic (AUROC), sensitivity, specificity, accuracy, positive predictive value, and negative predictive value. The primary outcomes were the prediction sensitivity and specificity of the model to assist cyto-diagnosis of thyroid nodules. Findings The AUROC of TBSRTC III+ (which distinguishes benign from TBSRTC classes III, IV, V, and VI) was 0·930 (95% CI 0·921–0·939) for Sun Yat-sen Memorial Hospital of Sun Yat-sen University (SYSMH) internal validation and 0·944 (0·929 – 0·959), 0·939 (0·924–0·955), 0·971 (0·938–1·000) for The First People's Hospital of Foshan (FPHF), Sichuan Cancer Hospital & Institute (SCHI), and The Third Affiliated Hospital of Guangzhou Medical University (TAHGMU) medical centres, respectively. The AUROC of TBSRTC V+ (which distinguishes benign from TBSRTC classes V and VI) was 0·990 (95% CI 0·986–0·995) for SYSMH internal validation and 0·988 (0·980–0·995), 0·965 (0·953–0·977), and 0·991 (0·972–1·000) for FPHF, SCHI, and TAHGMU medical centres, respectively. For the prospective study at SYSMH, the AUROC of TBSRTC III+ and TBSRTC V+ was 0·977 and 0·981, respectively. With the assistance of AI, the specificity of junior cytopathologists was boosted from 0·887 (95% CI 0·8440–0·922) to 0·993 (0·974–0·999) and the accuracy was improved from 0·877 (0·846–0·904) to 0·948 (0·926–0·965). 186 atypia of undetermined significance samples from 186 patients with BRAF mutation information were collected; 43 of them harbour the BRAF V600E mutation. 91% (39/43) of BRAF V600E -positive atypia of undetermined significance samples were identified as malignant by the AI models. Interpretation In this study, we developed an AI-assisted model named the Thyroid Patch-Oriented WSI Ensemble Recognition (ThyroPower) system, which facilitates rapid and robust cyto-diagnosis of thyroid nodules, potentially enhancing the diagnostic capabilities of cytopathologists. Moreover, it serves as a potential solution to mitigate the scarcity of cytopathologists. Funding Guangdong Science and Technology Department. Translation For the Chinese translation of the abstract see Supplementary Materials section.

A study of machine learning models for rapid intraoperative diagnosis of thyroid nodules for clinical practice in China

Deep learning models for thyroid nodules diagnosis of fine-needle aspiration biopsy: a retrospective, prospective, multicentre study in China

Combined Fine-Needle Aspiration and Selective Intraoperative Frozen Section to Optimize Prediction of Malignant Thyroid Nodules: A Retrospective Cohort Study of More Than 3000 Patients

Deep learning-based artificial intelligence model to assist thyroid nodule diagnosis and management: a multicentre diagnostic study

Deep learning diagnostic performance and visual insights in differentiating benign and malignant thyroid nodules on ultrasound images

Deep learning to predict cervical lymph node metastasis from intraoperative frozen section of tumour in papillary thyroid carcinoma: a multicentre diagnostic study

Rule-based automatic diagnosis of thyroid nodules from intraoperative frozen sections using deep learning

Improving the diagnosis of thyroid cancer by machine learning and clinical data

Value of Artificial Intelligence in Improving the Accuracy of Diagnosing TI-RADS Category 4 Nodules

Clinical evaluation of malignancy diagnosis of rare thyroid carcinomas by an artificial intelligent automatic diagnosis system

Automatic detection of thyroid nodules with a real-time artificial intelligence system in a real clinical scenario and the associated influencing factors

AI diagnosis of Bethesda category IV thyroid nodules

The clinical value of artificial intelligence in assisting junior radiologists in thyroid ultrasound: a multicenter prospective study from real clinical practice

From Bench-to-Bedside: How Artificial Intelligence Is Changing Thyroid Nodule Diagnostics

The Auxiliary Diagnosis of Thyroid Echogenic Foci Based on a Deep Learning Segmentation Model: A Two-Center Study

Pathology diagnosis of intraoperative frozen thyroid lesions assisted by deep learning

Video-based AI module with raw-scale and ROI-scale information for thyroid nodule diagnosis

Utilizing machine learning for early screening of thyroid nodules: a dual-center cross-sectional study in China

Multiple-Instance Learning for thyroid gland disease classification: A hands-on experience

A Comparative Analysis of Six Machine Learning Models Based on Ultrasound to Distinguish the Possibility of Central Cervical Lymph Node Metastasis in Patients With Papillary Thyroid Carcinoma